SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AmylyxPRNewsWire • 04/04/24
Levi & Korsinsky Reminds Amylyx Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 9, 2024 - AMLXAccesswire • 04/04/24
Amylyx Pharmaceuticals Announces Formal Intention to Remove RELYVRIO®/ALBRIOZA™ from the Market; Provides Updates on Access to Therapy, Pipeline, Corporate Restructuring, and StrategyBusiness Wire • 04/04/24
Shareholders that lost money on Amylyx Pharmaceuticals, Inc.(AMLX) should contact Levi & Korsinsky about pending Class Action - AMLXAccesswire • 04/04/24
Amylyx Pharmaceuticals, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 9, 2024 to Discuss Your Rights - AMLXAccesswire • 04/03/24
Shareholders of Amylyx Pharmaceuticals, Inc. Should Contact Levi & Korsinsky Before April 9, 2024 to Discuss Your Rights - AMLXPRNewsWire • 04/03/24
Shareholders that lost money on Amylyx Pharmaceuticals, Inc. (AMLX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreAccesswire • 04/02/24
FINAL DEADLINE NEXT WEEK: The Schall Law Firm Encourages Investors in Amylyx Pharmaceuticals, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 04/02/24
The Gross Law Firm Reminds Amylyx Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 9, 2024 - AMLXPRNewsWire • 04/02/24
Levi & Korsinsky Notifies Shareholders of Amylyx Pharmaceuticals, Inc. (AMLX) of a Class Action Lawsuit and an Upcoming DeadlineAccesswire • 04/02/24
Class Action Filed Against Amylyx Pharmaceuticals, Inc. (AMLX) Seeking Recovery for Investors – Contact Levi & KorsinskyAccesswire • 04/02/24
FINAL DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in Amylyx Pharmaceuticals, Inc. with Losses to Contact the FirmAccesswire • 04/01/24
Class Action Filed Against Amylyx Pharmaceuticals, Inc. (AMLX) - April 9, 2024 Deadline to Join - Contact Levi & KorsinskyAccesswire • 04/01/24
Shareholders that lost money on Amylyx Pharmaceuticals, Inc.(AMLX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreAccesswire • 03/31/24
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Amylyx Pharmaceuticals, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 03/31/24
AMYLYX PHARMACEUTICALS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Amylyx Pharmaceuticals, Inc. - AMLXPRNewsWire • 03/30/24
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AmylyxPRNewsWire • 03/29/24
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Amylyx Pharmaceuticals, Inc.(AMLX) ShareholdersPRNewsWire • 03/29/24
Levi & Korsinsky Notifies Amylyx Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - AMLXAccesswire • 03/29/24
Levi & Korsinsky Notifies Amylyx Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – AMLXAccesswire • 03/29/24
Lost Money on Amylyx Pharmaceuticals, Inc.(AMLX)? Join Class Action Suit Seeking Recovery – Contact Levi & KorsinskyAccesswire • 03/28/24
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Amylyx Pharmaceuticals, Inc. (AMLX) ShareholdersAccesswire • 03/28/24